Biotechnology Industry News

 One of the major factors fuelling the boom of the microbiology cell culture industry in Saudi Arabia is the blossoming life sciences sector the country. The life sciences sector in Saudi Arabia is being mainly driven by the increasing healthcare expenditure in the country. For instance, King Abdulaziz City for Science and Technology (KACST) made an investment of $373.0 million on health biotechnology research projects in the country under the National Science, Technology, and Innovation Plan (NSTIP), in 2016, in order to study certain rare conditions and for the diagnosis and treatment of various kinds of diseases in the country. Receive Sample Copy of this Report:  https://www.psmarketresearch.com/market-analysis/saudi-arabia-microbiology-cell-culture-market/report-sample In Saudi Arabia, the microbiology cell culture processes are widely adopted by pharmaceutical and biotechnology companies, academic and research institutes, and food and beverage companies. Amongst these, t...

 The increasing number of technological developments in the healthcare industry is one of the major factors fuelling the surge in the demand for next-generation antibody therapeutics solutions throughout the globe. For instance, there have been major developments in the healthcare technologies over the last few years such as the development of bispecific antibodies (BsAbs), ADC technologies, and glycoengineered antibody. These advancements have significantly increased the application area of the antibody therapeutics. The other major factor propelling the demand for next-generation antibody therapeutics solutions is the increasing prevalence of chronic diseases across the world. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample ADCs are widely considered to be much safer and effective than the conventionally used antibodies for cancer treatment as these are made by combining a biologically active cytot...

Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample This is concurrent with the fact that among the genomics, proteomics, metabolomics, and epigenetics techniques, genomics is the most widely used one. As the root cause of the cancer can be determined by studying which gene mutated and how, targeted therapies can be devised. Such analysis can also help ascertain if the patient would be at risk of a relapse. All these techniques and technologies find ...

One of the biggest factors propelling the demand for organ-on-chip is the increasing number of investments being made in research by the governments of several countries all around the world.   For instance, the National Center for Advancing Translational Sciences (NCATS) gave a research grant worth $2 million to Emulate Inc. in July 2017, in order to allow the company to leverage its human Brain-Chip system and create a fully automated research platform for conducting experiments on the International Space Station. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market/report-sample The other major factor responsible for the rising demand for organ-on-chip is the increasing need for alternatives to the conventionally used animal models in research activities. In many countries, doctors and medical researchers are raising concerns over the scientific validity and translatability of the animal alternatives of human diseases and...

Soaring number of initiatives by governments and private organizations for creating awareness amongst the people about the health and environmental benefits of alternative protein sources is one of the major factors responsible for the rise in the demand for protein extracts from single cell protein sources across the world. For instance, Valensa International, which is a major producer of microalgae-based nutraceuticals launched an alliance with a U.S. based trade organization called Algae Biomass Organization (ABO) in 2017 in order to create awareness amongst the masses about the consumption of microalgae as an alternative protein source.   Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/protein-extracts-from-single-cell-protein-sources-market/report-sample Due to the above-mentioned factors, the revenue generated from the worldwide sales of protein extracts from single protein sources will increase from $5.3 billion to $8.7 billion from 2...

Though there are a set number of health conditions that can affect people, the actual effect they have can vary from one individual to another. This is because, though similar, every human is slightly different on the genetic level. Consequently, one treatment that works for one patient has no guarantee of working for another. With the realization of this fact, the medical specialty of personalized medicine has emerged, wherein the genetics of a person are studied to devise a suitable treatment. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample With extensive research and development (R&D), scientists have realized that a lot of diseases are caused by mutations in a particular gene, and if that particular gene is somehow deactivated, the disease could be managed. One of the ways it is being done is by artificially producing an antisense oligonucleotide, which is a single-strand deoxyribonucleic a...

  Cancer kills over 9.5 million people each year, as per the World Health Organization (WHO), which makes it the second leading cause of human mortality. With the increasing prevalence of this disease in developed as well as developing countries, the pressure on the medical fraternity to find an effective treatment is increasing. Though there are numerous therapies available, such as surgery, radiation, chemotherapy, and targeted medication, cancer has a high chance of coming back. This is why extensive research is being put in by pharmaceutical and biotechnology companies. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample Two of the novel and most promising answers to cancer that such activities have yielded thus far are monoclonal antibodies (mAb) and proteins. To produce both these biopharmaceuticals, laboratories require something known as protein A resin. Thus, with the increasing focus on protein-base...